WHAT DOES LINK ALTERNATIF MBL77 MEAN?

For patients with symptomatic sickness requiring therapy, ibrutinib is often advised according to four stage III randomized clinical trials evaluating ibrutinib with chlorambucil monotherapy106 and various typically applied CIT combos, specifically FCR, bendamustine furthermore rituximab and chlorambucil plus obinutuzumab (ClbO).107–109 Ibrutinib